608 results on '"Hernández-Laín A"'
Search Results
2. 20484. MIOPATÍAS MITOCONDRIALES PRIMARIAS: CARACTERÍSTICAS BASALES Y POTENCIALES BIOMARCADORES A PARTIR DE UN ESTUDIO DE HISTORIA NATURAL
3. 20624. CARACTERÍSTICAS CLÍNICAS, PATOLÓGICAS Y GENÉTICAS DE 27 PACIENTES CON TRASTORNOS CAUSADOS POR VARIANTES PATOGÉNICAS EN POLG
4. 20481. MIOPATÍA DISTAL DOMINANTE DE INICIO EN LA EDAD ADULTA POR UNA NUEVA VARIANTE EN HETEROCIGOSIS EN EL GEN ACTN2
5. 115. CASO CLÍNICO-PATOLÓGICO. VARÓN CON TRASPLANTE CARDÍACO Y MÚLTIPLES LESIONES CEREBRALES
6. 124. ENFERMEDAD MITOCONDRIAL. BIOPSIA MUSCULAR Y GDF15
7. 117. POLIMIOSITIS CON FIBRAS COX NEGATIVAS. PRESENTACIÓN DE DOS CASOS Y REVISIÓN DE LA LITERATURA
8. Distal hereditary motor neuronopathy as a new phenotype associated with variants in BAG3
9. 20707. SERIE DE CASOS DE MIOPATÍAS DE PREDOMINIO AXIAL
10. 20424. AUSENCIA DE MUTACIONES PATOGÉNICAS Y FUERTE ASOCIACIÓN CON HLA-DRB1*11:01 EN PACIENTES JÓVENES NO EXPUESTOS A ESTATINAS CON MIOPATÍA NECROTIZANTE ANTI-HMGCR
11. 20675. CARACTERÍSTICAS SEROLÓGICAS, HISTOPATOLÓGICAS Y DIFICULTADES TERAPÉUTICAS DE UNA SERIE DE PACIENTES CON MIOPATÍA BRAQUIOCERVICAL INFLAMATORIA (BCIM)
12. NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma
13. Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients
14. Cerebral amyloid angiopathy–related inflammation: clinical features and treatment response in a case series
15. Inflamación relacionada con angiopatía amiloide: características clínicas y respuesta al tratamiento en una serie de casos
16. Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure
17. Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome
18. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
19. BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients
20. A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
21. The mechanoreceptor PIEZO1 is a novel oncogene in glioma by promoting astrocyte reactivity
22. Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report
23. Biallelic variants in SNUPN cause a limb girdle muscular dystrophy with myofibrillar-like features.
24. Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma.
25. A novel mutation in the mitochondrial MT-ND5 gene in a family with MELAS. The relevance of genetic analysis on targeted tissues
26. A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis
27. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)
28. Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival
29. Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome.
30. BBB dysfunction drives neurotoxic myeloid cells in glioblastoma and Alzheimer’s disease
31. Normal tissue content impact on the GBM molecular classification.
32. Recurrent rhabdomyolysis and exercise intolerance: A new phenotype of late-onset thymidine kinase 2 deficiency
33. Localized Bilateral Superior and Inferior Orbital Neurofibroma in the Absence of Neurofibromatosis
34. Evaluación de la correlación entre degeneración histológica y parámetros radiológicos o clínicos en una serie de pacientes operados por hernia discal lumbar
35. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab
36. BBB Dysfunction Defines the Aging Myeloid Landscape Favoring Immune Evasion for Glioma and Alzheimer's Disease
37. Genetic diagnosis of Duchenne and Becker muscular dystrophy through mRNA analysis: new splicing events
38. Congenital Ophthalmoplegia and Late-Onset Limb Weakness Caused by MUSK Mutations
39. STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis
40. A novel MLIP truncating variant in an 80-year-old patient with late-onset progressive weakness
41. BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients
42. Expanding the phenotypic spectrum ofTRAPPC11-related muscular dystrophy: 25 Roma individuals carrying a founder variant
43. Delayed Diagnosis of Congenital Myasthenic Syndromes Erroneously Interpreted as Mitochondrial Myopathies
44. Abstract 5105: TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis
45. Supplementary Methods from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
46. Supplementary Figure 5 from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
47. Supplementary Figure 4 from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
48. Supplementary Table S3b from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
49. Supplementary Figure 2 from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
50. Data from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.